Alteration of the sexual response cycle in women using combined oral contraceptives

Fuente: Redalyc
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Franklin José Espitia De La Hoz
Format: Artículo científico
Sprache:en
Veröffentlicht: Universidad del Norte 2018
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1876457987590062080
author Franklin José Espitia De La Hoz
author_facet Franklin José Espitia De La Hoz
contents Alteration of the sexual response cycle in women using combined oral contraceptives Franklin José Espitia De La Hoz Hoover Orozco Gallego Salud Women Androgens Sexuality Testosterone Contraceptive Agents Objective: To estimate the effect of female sexuality due to the use of the contraceptive combination estradiol valerate / Dienogest against Ethinylestradiol / Drospirenone.Material and methods: A controlled, randomized, unblinded clinical trial was carried out on 174 women, between 18 and 39 years of age, who underwent two hormonal contraceptive options with estradiol valerate / Dienogest and ethinylestradiol / Drospirenone; in a private clinic in Armenia, Quindío, between 2013 and 2017. The female sexual function index (IFSF) was used to analyze the sexual function of the participating women; at the beginning, at six, at eighteen and thirty-six months after the start of the contraceptive.Results: At the end of the study, the contraceptive combination estradiol valerate / Dienogest was a less aggressive therapy in the alteration of the sexual response cycle of the users, while the ethinylestradiol / drospirenone combination significantly affects the desire and excitement with lower scores in the IFSF.Conclusions: The results indicate that the estradiol valerate / Dienogest combination affects the desire, arousal and IFSF score less than the ethinylestradiol / drospirenone combination. 2018 artículo científico 0120-5552 https://www.redalyc.org/articulo.oa?id=81759552018 https://www.redalyc.org/journal/817/81759552018/ https://www.redalyc.org/journal/817/81759552018/html/ https://www.redalyc.org/journal/817/81759552018/81759552018.epub https://www.redalyc.org/journal/817/81759552018/movil 10.14482/sun.34.2.613.94 en http://www.redalyc.org/revista.oa?id=817 Salud Uninorte application/pdf Universidad del Norte Salud Uninorte (Colombia) Num.2 Vol.34
format Artículo científico
id redalyc_81759552018
institution Redalyc
language en
publishDate 2018
publisher Universidad del Norte
spellingShingle Alteration of the sexual response cycle in women using combined oral contraceptives
Franklin José Espitia De La Hoz
Salud
Women
Androgens
Sexuality
Testosterone
Contraceptive Agents
Alteration of the sexual response cycle in women using combined oral contraceptives Franklin José Espitia De La Hoz Hoover Orozco Gallego Salud Women Androgens Sexuality Testosterone Contraceptive Agents Objective: To estimate the effect of female sexuality due to the use of the contraceptive combination estradiol valerate / Dienogest against Ethinylestradiol / Drospirenone.Material and methods: A controlled, randomized, unblinded clinical trial was carried out on 174 women, between 18 and 39 years of age, who underwent two hormonal contraceptive options with estradiol valerate / Dienogest and ethinylestradiol / Drospirenone; in a private clinic in Armenia, Quindío, between 2013 and 2017. The female sexual function index (IFSF) was used to analyze the sexual function of the participating women; at the beginning, at six, at eighteen and thirty-six months after the start of the contraceptive.Results: At the end of the study, the contraceptive combination estradiol valerate / Dienogest was a less aggressive therapy in the alteration of the sexual response cycle of the users, while the ethinylestradiol / drospirenone combination significantly affects the desire and excitement with lower scores in the IFSF.Conclusions: The results indicate that the estradiol valerate / Dienogest combination affects the desire, arousal and IFSF score less than the ethinylestradiol / drospirenone combination. 2018 artículo científico 0120-5552 https://www.redalyc.org/articulo.oa?id=81759552018 https://www.redalyc.org/journal/817/81759552018/ https://www.redalyc.org/journal/817/81759552018/html/ https://www.redalyc.org/journal/817/81759552018/81759552018.epub https://www.redalyc.org/journal/817/81759552018/movil 10.14482/sun.34.2.613.94 en http://www.redalyc.org/revista.oa?id=817 Salud Uninorte application/pdf Universidad del Norte Salud Uninorte (Colombia) Num.2 Vol.34
title Alteration of the sexual response cycle in women using combined oral contraceptives
topic Salud
Women
Androgens
Sexuality
Testosterone
Contraceptive Agents
url https://www.redalyc.org/articulo.oa?id=81759552018
https://www.redalyc.org/journal/817/81759552018/
https://www.redalyc.org/journal/817/81759552018/html/
https://www.redalyc.org/journal/817/81759552018/81759552018.epub
https://www.redalyc.org/journal/817/81759552018/movil